Beamion LUNG-1 And LUNG-2: The Zongertinib Clinical Program in Patients with Non-Small Cell Lung Cancer and HER2 Mutations

被引：0
|
作者：
Wu, Y. -L. [1 ]
Opdam, F. [2 ]
Yamamoto, N. [3 ]
Yoshida, T. [3 ]
Heymach, J. [4 ]
机构：
[1] Southern Med Univ, Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Natl Canc Ctr, Chuo Ku, Tokyo, Japan
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12D.06
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [31] HercepTest: HER2 expression and gene amplification in non-small cell lung cancer
    Cox, G
    Vyberg, M
    Melgaard, B
    Askaa, J
    Oster, A
    O'Byrne, KJ
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) : 480 - 483
  • [32] Her2 gene amplification and protein expression in non-small cell lung cancer
    Cox, G
    Vyberg, M
    Melgaard, B
    O'Byrne, KJ
    THORAX, 2000, 55 : A85 - A85
  • [33] EGFR and HER2/NEU in gefitinib chemotherapy for non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2008, 53 : 406 - 406
  • [34] Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC)
    Pitiyarachchi, Omali
    Tan, Aaron C.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02)
  • [35] Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations
    Ni, Jun
    Zhang, Li
    ONCOTARGETS AND THERAPY, 2021, 14 : 4087 - 4098
  • [36] The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
    Nagasaka, Misako
    Singh, Vijendra
    Baca, Yasmine
    Sukari, Ammar
    Kim, Chul
    Mamdani, Hirva
    Spira, Alexander, I
    Uprety, Dipesh
    Bepler, Gerold
    Kim, Edward S.
    Raez, Luis E.
    Pai, Sachin Gopalkrishna
    Ikpeazu, Chukwuemeka
    Oberley, Matthew
    Feldman, Rebecca
    Xiu, Joanne
    Korn, W. Michael
    Wozniak, Antoinette J.
    Borghaei, Hossein
    Liu, Stephen, V
    CLINICAL LUNG CANCER, 2022, 23 (01) : 52 - 59
  • [37] The role of HER2/neu expression and trastuzumab in non-small cell lung cancer
    Hirsch, FR
    Langer, CJ
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 75 - 82
  • [38] HER2 Transmembrane Domain Mutations: Rare New Target for Non-Small Cell Lung Cancer Therapy
    Notsuda, Hirotsugu
    Bradbury, Penelope A.
    Tsao, Ming-Sound
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 422 - 424
  • [39] Treatment outcome and clinical characteristics of HER2 mutated advanced non-small cell lung cancer patients in China
    Xu, Fei
    Yang, Guangjian
    Xu, Haiyan
    Yang, Lu
    Qiu, Weini
    Wang, Yan
    THORACIC CANCER, 2020, 11 (03) : 679 - 685
  • [40] Screening for HER2 alterations and HER2-targeted therapy in non-small cell lung cancer
    Kinoshita, Ichiro
    ANNALS OF ONCOLOGY, 2015, 26 : 40 - 40
12345